MP

Mouscron Pharma

BE0442.796.288

Gross margin
€ 310K ↓ 14% 2025 Total € 5.89M
Profit
€ 70K ↓ 24% 2025 Total € 2.19M
EBITDA
€ 152K ↓ 5% 2025 Total € 3.43M
EBIT
€ 51K ↓ 12% 2025 Total € 2.27M
Net profit
€ 70K ↓ 24% 2025 Total € 2.19M
Capex
€ 0 ↓ 100% 2025 Total € 1.73M
Assets
€ 3.25M ↓ 4% 2025
Equity
€ 2.03M ↑ 4% 2025
Debt
€ 1.22M ↓ 15% 2025
Cash
€ 124K ↑ 2% 2025
Cashflow
€ 171K ↓ 12% 2025 Total € 3.34M
Working capital
€ 1.45M ↑ 13% 2025
Current ratio
2.20 ↑ 16% 2025
Quick ratio
1.56 ↑ 7% 2025
Working capital ratio
2.20 ↑ 16% 2025
Debt
€ 1.22M ↓ 15% 2025
Short-term debt
€ 1.22M ↓ 15% 2025
Debt / EBITDA
7.98 ↓ 11% 2025
Solvability
62.6% ↑ 4.8 pt 2025
Gross profitability
8.4% ↓ 1.5 pt 2025
Net profitability
3.5% ↓ 1.3 pt 2025
Return On Assets (ROA)
2.16 ↓ 21% 2025
Return On Equity (ROE)
3.45 ↓ 27% 2025
Taxes
€ 8K ↓ 56% 2025 Total € 565K
Salaries and Social Security Contributions
€ 18K ↑ 6% 2025 Total € 299K
Employees
2.80 2025
Staff cost per employee
€ 6K ↑ 6% 2025
Dividends
€ 970K ↑ 4028% 2023 Total € 1.00M
Dividend payout
1,160.3% ↑ 1150.8 pt 2023